Biocept Inc. (BIOCQ) — Capital Reinvestment Ratio
Latest as of December 2021:
0.43x
Biocept Inc. (BIOCQ) has a Capital Reinvestment Ratio of 0.43x as of December 2021, meaning it reinvests 0% of its operating cash flow ($3.69 Million) in capital expenditures ($1.57 Million). See BIOCQ FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.43x
Capex / Operating Cash Flow
Operating Cash Flow
$3.69 Million
USD
Capital Expenditures
$1.57 Million
USD
Data as of
Dec 2021
Most recent filing
Biocept Inc. Capital Reinvestment Ratio (2021–2021)
This chart tracks Biocept Inc.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Biocept Inc. (2021–2021)
Year-by-year Capital Reinvestment Ratio for Biocept Inc. from 2021 to 2021. For live market cap and broader valuation context, see Biocept Inc. market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.43x | $3.69 Million | $1.57 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow